BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noronha V, Abraham G, Patil V, Joshi A, Menon N, Mahajan A, Janu A, Jain S, Talreja VT, Kapoor A, Kumar Singh G, Khaddar S, Gupta K, Rathinasamy N, Srinivas S, Agrawal A, Ventrapati P, Prabhash K. A real-world data of Immune checkpoint inhibitors in solid tumors from India. Cancer Med 2021;10:1525-34. [PMID: 33591635 DOI: 10.1002/cam4.3617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, Nawale K, Jogdhankar S, Tambe R, Dhumal S, Sawant R, Alone M, Karla D, Peelay Z, Pathak S, Balaji A, Kumar S, Purandare N, Agarwal A, Puranik A, Mahajan A, Janu A, Kumar Singh G, Mittal N, Yadav S, Banavali S, Prabhash K. Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study. J Clin Oncol 2023;41:222-32. [PMID: 36265101 DOI: 10.1200/JCO.22.01015] [Reference Citation Analysis]
2 Patel A, Akhade A. Pembrolizumab Weight-Based Dosing: Conviction and Lacunae in Adopting a Cost-Saving Approach—A Survey Report. Indian J Med Paediatr Oncol. [DOI: 10.1055/s-0042-1745814] [Reference Citation Analysis]
3 Patel A, Akhade A, Parikh P, Sharma A, Malhotra H, Prabhash K, Babu G, Noronha V, Batra U, Mehta P, Gupta VG, Radhakrishnan V, Boya RR, Biswas B. Pembrolizumab weight based dosing – A call for policy change. Indian J Med Paediatr Oncol. [DOI: 10.1055/s-0042-1742651] [Reference Citation Analysis]
4 Akhade A, Sirohi B, Gyawali B. Global consequences of the US FDA's accelerated approval of cancer drugs. The Lancet Oncology 2022;23:201-3. [DOI: 10.1016/s1470-2045(21)00709-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Noronha V, Abraham G, Patil V, Joshi A, Menon N, Mahajan A, Janu A, Jain S, Talreja VT, Kapoor A, Kumar Singh G, Khaddar S, Gupta K, Rathinasamy N, Srinivas S, Agrawal A, Ventrapati P, Prabhash K. A real-world data of Immune checkpoint inhibitors in solid tumors from India. Cancer Med 2021;10:1525-34. [PMID: 33591635 DOI: 10.1002/cam4.3617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]